Logo image of EXOD

EXODUS MOVEMENT INC - A (EXOD) Stock Fundamental Analysis

NYSEARCA:EXOD - NYSE Arca - US30209R1068 - Common Stock - Currency: USD

29.99  +3.45 (+13%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to EXOD. EXOD was compared to 283 industry peers in the Software industry. EXOD has an excellent financial health rating, but there are some minor concerns on its profitability. EXOD has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

EXOD had positive earnings in the past year.
In the past year EXOD has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: EXOD reported negative net income in multiple years.
In multiple years EXOD reported negative operating cash flow during the last 5 years.
EXOD Yearly Net Income VS EBIT VS OCF VS FCFEXOD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2024 0 20M -20M 40M 60M 80M 100M

1.2 Ratios

EXOD has a better Return On Assets (17.21%) than 92.58% of its industry peers.
EXOD's Return On Equity of 18.75% is amongst the best of the industry. EXOD outperforms 85.51% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.17%, EXOD belongs to the top of the industry, outperforming 85.51% of the companies in the same industry.
Industry RankSector Rank
ROA 17.21%
ROE 18.75%
ROIC 9.17%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EXOD Yearly ROA, ROE, ROICEXOD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2024 0 20 -20 40

1.3 Margins

EXOD has a better Profit Margin (36.77%) than 96.82% of its industry peers.
Looking at the Operating Margin, with a value of 22.09%, EXOD belongs to the top of the industry, outperforming 90.46% of the companies in the same industry.
EXOD's Operating Margin has declined in the last couple of years.
EXOD's Gross Margin of 70.74% is in line compared to the rest of the industry. EXOD outperforms 55.83% of its industry peers.
In the last couple of years the Gross Margin of EXOD has grown nicely.
Industry RankSector Rank
OM 22.09%
PM (TTM) 36.77%
GM 70.74%
OM growth 3Y-20.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.53%
GM growth 5Y42.83%
EXOD Yearly Profit, Operating, Gross MarginsEXOD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2024 0 50

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXOD is destroying value.
The number of shares outstanding for EXOD has been increased compared to 5 years ago.
There is no outstanding debt for EXOD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EXOD Yearly Shares OutstandingEXOD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2024 5M 10M 15M 20M 25M
EXOD Yearly Total Debt VS Total AssetsEXOD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2024 50M 100M 150M 200M 250M

2.2 Solvency

EXOD has an Altman-Z score of 22.93. This indicates that EXOD is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 22.93, EXOD belongs to the top of the industry, outperforming 94.70% of the companies in the same industry.
EXOD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 22.93
ROIC/WACC0.82
WACC11.2%
EXOD Yearly LT Debt VS Equity VS FCFEXOD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 11.48 indicates that EXOD has no problem at all paying its short term obligations.
EXOD's Current ratio of 11.48 is amongst the best of the industry. EXOD outperforms 95.05% of its industry peers.
EXOD has a Quick Ratio of 11.48. This indicates that EXOD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 11.48, EXOD belongs to the top of the industry, outperforming 95.05% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 11.48
Quick Ratio 11.48
EXOD Yearly Current Assets VS Current LiabilitesEXOD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2024 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

Measured over the past years, EXOD shows a very strong growth in Revenue. The Revenue has been growing by 71.14% on average per year.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125.8%
Revenue 1Y (TTM)N/A
Revenue growth 3Y6.65%
Revenue growth 5Y71.14%
Sales Q2Q%23.87%

3.2 Future

The Earnings Per Share is expected to decrease by -10.15% on average over the next years. This is quite bad
The Revenue is expected to grow by 37.45% on average over the next years. This is a very strong growth
EPS Next Y-47.01%
EPS Next 2Y-10.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year47.88%
Revenue Next 2Y37.45%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
EXOD Yearly Revenue VS EstimatesEXOD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
EXOD Yearly EPS VS EstimatesEXOD Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.5 1 1.5 2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 23.25 indicates a rather expensive valuation of EXOD.
EXOD's Price/Earnings ratio is a bit cheaper when compared to the industry. EXOD is cheaper than 78.80% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.29. EXOD is around the same levels.
EXOD is valuated correctly with a Price/Forward Earnings ratio of 15.53.
EXOD's Price/Forward Earnings ratio is rather cheap when compared to the industry. EXOD is cheaper than 85.16% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.17. EXOD is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 23.25
Fwd PE 15.53
EXOD Price Earnings VS Forward Price EarningsEXOD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EXOD is valued a bit cheaper than the industry average as 79.86% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 21.61
EXOD Per share dataEXOD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The decent profitability rating of EXOD may justify a higher PE ratio.
EXOD's earnings are expected to decrease with -10.15% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.15%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

EXOD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EXODUS MOVEMENT INC - A

NYSEARCA:EXOD (6/3/2025, 3:20:43 PM)

29.99

+3.45 (+13%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-11 2025-08-11
Inst Owners0.13%
Inst Owner Change8910.67%
Ins Owners18.05%
Ins Owner Change5.47%
Market Cap862.51M
Analysts87.27
Price Target53.35 (77.89%)
Short Float %6.18%
Short Ratio1.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.04%
Min EPS beat(2)-65.46%
Max EPS beat(2)47.39%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)18.67%
Min Revenue beat(2)-5.68%
Max Revenue beat(2)43.03%
Revenue beat(4)1
Avg Revenue beat(4)0.18%
Min Revenue beat(4)-18.8%
Max Revenue beat(4)43.03%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-12.83%
EPS NQ rev (1m)5.65%
EPS NQ rev (3m)-3.68%
EPS NY rev (1m)0%
EPS NY rev (3m)255%
Revenue NQ rev (1m)10.14%
Revenue NQ rev (3m)17.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)20.42%
Valuation
Industry RankSector Rank
PE 23.25
Fwd PE 15.53
P/S 7
P/FCF N/A
P/OCF N/A
P/B 3.57
P/tB 14.68
EV/EBITDA 21.61
EPS(TTM)1.29
EY4.3%
EPS(NY)1.93
Fwd EY6.44%
FCF(TTM)-0.66
FCFYN/A
OCF(TTM)-0.65
OCFYN/A
SpS4.28
BVpS8.4
TBVpS2.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 17.21%
ROE 18.75%
ROCE 10.62%
ROIC 9.17%
ROICexc 12.14%
ROICexgc 219.94%
OM 22.09%
PM (TTM) 36.77%
GM 70.74%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-4.25%
ROICexcg growth 5YN/A
ROICexc growth 3Y-46.6%
ROICexc growth 5YN/A
OM growth 3Y-20.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.53%
GM growth 5Y42.83%
F-ScoreN/A
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 7.3%
Cap/Sales 0.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.48
Quick Ratio 11.48
Altman-Z 22.93
F-ScoreN/A
WACC11.2%
ROIC/WACC0.82
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125.8%
EPS Next Y-47.01%
EPS Next 2Y-10.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3Y6.65%
Revenue growth 5Y71.14%
Sales Q2Q%23.87%
Revenue Next Year47.88%
Revenue Next 2Y37.45%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3Y-15.6%
EBIT growth 5YN/A
EBIT Next Year10.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A